Interestingly, we saw no angiosarcomas in the Pdgfrb-Cre, p53fl/fl mice suggesting that the Trp53R172H mutant is exerting a gain-of-function activity that is required for angiosarcoma development when Pdgfrb cells are targeted. Here, PDGFRB is linked to angiosarcoma.